Zydus Cadila gets USFDA nod for blood pressure treatment drug Ruby Khatun Khatun30 Nov 2017 10:45 AM ISTNew Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
Zydus gets USFDA nod for seizure, migraine drug Ruby Khatun Khatun28 Nov 2017 1:53 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
Aurobindo looks for inorganic growth prospects in East Europe Ruby Khatun Khatun27 Nov 2017 10:40 AM ISTMumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...
Roche Diabetes Care eyes 51 percent market share in India by 2019 Ruby Khatun Khatun27 Nov 2017 10:18 AM ISTNew Delhi: Roche Diabetes Care India is aiming to have up to 51 percent market share in blood glucose monitoring segment in the country by the end of...
Zydus Cadila gets USFDA nod to sell erectile dysfunction drug Ruby Khatun Khatun24 Nov 2017 11:05 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
Ajanta Pharma launches generic ADHD treatment drug in US Ruby Khatun Khatun23 Nov 2017 10:15 AM ISTNew Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
Dr Reddy's gets EIR for Vizag plant, but inspection not closed Ruby Khatun Khatun22 Nov 2017 11:06 AM ISTNew Delhi: Dr. Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for its formulation...
Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal Ruby Khatun Khatun22 Nov 2017 10:45 AM ISTNew Delhi: Shares of Eris Lifesciences and Strides Shasun rose by as much as 7 percent after both the companies entered into a definitive pact to buy...
Divis Lab Vizag unit gets USFDA EIR with 6 observations Ruby Khatun Khatun20 Nov 2017 10:45 AM ISTNew Delhi: Drug firm Divis Laboratories on Saturday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Zydus Cadila gets USFDA nod for swelling reducing drug Ruby Khatun Khatun20 Nov 2017 10:02 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report Ruby Khatun Khatun18 Nov 2017 4:31 PM ISTMUMBAI: Eris Life Sciences is going to acquire Stride Shasun India branded formulations business as the company has agreed to sell it for Rs 500 crore...
Glenmark Pharmaceuticals launches nicotine gum Kwitz Ruby Khatun Khatun18 Nov 2017 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has launched nicotine replacement therapy product Kwitz that helps smokers quit smoking.Kwitz nicotine gum...
